Mallinckrodt, Medtronic Announce Clinical and Commercial Collaboration

Mallinckrodt MNK announced today that it has entered into a multiyear agreement with Medtronic MDT to advance availability in the U.S. of intrathecal therapeutics for the treatment of chronic pain and severe spasticity. See full press release